Cairo – Mubasher: Arab Drug Co. said it has completed nearly 34.5% of the projects it announced earlier through its rights Issue Prospectus.
The drug firm increased earlier, its capital by EGP 19.5 million through a rights issue to existing shareholders at par value of EGP 10 per share plus issuing fees of EGP 0.25 per share.
The company used the proceeds of its rights issue in buying two production lines, in addition to other two machines.
The firm is currently capitalized at EGP 60 million, distributed across 6 million shares at EGP 10 par value each.
